Last edition
News about Ingredients
Glenmark Pharma releases interim data from PMS study on favipiravir
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, announced interim data of 503 patients from its post marketing surveillance (PMS) study on favipiravir in India. The PMS study commenced in July 2020 aimed to evaluate safety and efficacy of favipiravir in mild to moderate Covid-19 patients
Ingredients | 09/06/2021 | By Darshana | 414
Biogen, Ginkgo Bioworks enter agreement to develop novel gene therapy manufacturing platform
Biogen and Ginkgo Bioworks announced a gene therapy collaboration. Together, the companies aim to redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors
Ingredients | 24/05/2021 | By Darshana | 279
Cipla ready to launch COVID-19 treatment drug favipiravir
Cipla is set to launch coronavirus COVID-19 treatment drug favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process
Ingredients | 24/07/2020 | By Darshana | 444
FDA Continues to Accelerate Development of Novel Therapies for COVID-19
As part of the Trump Administration's all-hands-on-deck approach across public, academic and private sectors to combat the COVID-19 pandemic, the U.S. Food and Drug Administration stood up a new program to expedite the development of potentially safe and effective life-saving treatments
Ingredients | 01/04/2020 | By Darshana | 641
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy